Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
90
about 9.6 years
18+
2 sites in NJ, PA
What this study is about
This trial is testing how radiosurgery affects the brain function of patients with multiple brain metastases. It compares the effects of stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS) on cognitive function and quality of life in these patients.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Quality-of-Life Assessment
- 2.Receive Stereotactic Body Radiation Therapy
- 3.Receive Stereotactic Radiosurgery
- +1 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: Change in symptom burden as measured by the MD Anderson Symptom Inventory- Brain Tumor Module (MDASI-BT), Incidence of adverse events graded according to the Common Terminology Criteria for Adverse Events version 5.0, Local control as measured by magnetic resonance imaging, Overall survival (OS), Progression free survival (PFS), Quality adjusted survival and health outcomes as measured by the European Quality of Life Five Dimension Five Level scale questionnaire (EQ-5D-5L)
radiation